cxxix Table 10.S5: Sub-analysis for IVF/ICSI Outcomes for Adenomyosis Patients versus Male Infertility Controls with only Fair-to-Super Embryos Adenomyosis Patients (N=95) Control Group (N=717) P-value Biochemical Pregnancy 25 (26.3%) 290 (40.4%) 0.010 Ongoing Pregnancy 16 (17.2%) 234 (32.6%) 0.002 Live Birth 14 (15.2%) 206 (28.7%) 0.014 Table 10.S6 Full IVF/ICSI Outcomes for MRI Markers for Adenomyosis/Endometriosis Patients versus Male Infertility Controls: IVF/ICSI Outcome Adenomyosis Patients Overall (N=124) Control Group (N=889) P-value Biochemical Pregnancy 31 (25%) 323 (36.3%) 0.013 Ongoing Pregnancy 19 (15.6%) 261 (29.4%) 0.001 Live Birth 17 (14.0%) 233 (26.8%) 0.009 Adenomyosis Patients without Myometrial Cysts (N=63) Adenomyosis Patients with Myometrial Cysts (N=60) Control Group (N=889) P-value* Biochemical Pregnancy 15 (23.8%) 15 (25.0%) 323 (36.3%) 0.033 Ongoing Pregnancy 10 (16.4%) 9 (15.0%) 261 (29.4%) 0.007 Live Birth 10 (16.1%) 7 (12.1%) 233 (26.8%) 0.052 Adenomyosis Patients with Mean JZ<12mm (N= 103) Adenomyosis Patients with Mean JZ>12mm (N= 20) Control Group (N=889) Biochemical Pregnancy 28 (27.2%) 3 (15.0%) 323 (36.3%) 0.031 Ongoing Pregnancy 17 (16.7%) 2 (10.5%)a 261 (29.4%) 0.006 Live Birth 15 (15.0%) 2 (10.5%) 233 (26.8%) 0.053 Adenomyosis Patients with JZ-Diff <5mm (N=13) Adenomyosis Patients with JZ-Diff>5mm (N= 110) Control Group (N=889) Biochemical Pregnancy 2 (15.4%) 29 (26.4%) 323 (36.3%) 0.039 Ongoing Pregnancy 1 (7.7%) 18 (16.7%)a 261 (29.4%) 0.005 Live Birth 1 (7.7%) 16 (15.0%) 233 (26.8%) 0.051 Adenomyosis Patients with JZ-Myometrium <40% (N=31) Adenomyosis Patients with JZ-Myometrium Ratio >40% (N=92) Control Group (N=889) Biochemical Pregnancy 9 (29.0%) 22 (23.9%) 323 (36.3%) 0.046 Ongoing Pregnancy 6 (19.4%) 13 (14.4%)a 261 (29.4%) 0.006
RkJQdWJsaXNoZXIy MTk4NDMw